CDE ID | CDE Description | * 421 | EDRN Participant ID (Go To: 866) |
* 866 | Date of follow-up visit: (Go To: 423) |
* 423 | EDRN Protocol ID (Go To: 422) |
* 422 | EDRN Site ID (Go To: 929) |
* 929 | EDRN Staff ID of the person who collected the data: (Go To: 1046) |
* 1046 | Is participant alive? (Go To: 905) |
| Permissible Values (value): | No (0) (Go To: 1048) |
|
| |
| | Unknown/refused (9) (Go To: 1218) |
|
1218 | Last date known alive (MM/DD/YYYY): (Go To: 905) |
1048 | Date of death (Go To: 1047) |
1047 | Cause of death: (Go To: 905) |
* 905 | New primary cancer [other than basal/squamous cell skin cancer] confirmed by a doctor since last routine study contact? (Have you been diagnosed with a new primary cancer [other than basal/squamous cell skin cancer] since your last routine study contact?) (Go To: 1711) |
| Permissible Values (value): | No (0) |
|
| |
| |
* 742 | Cancer type/location (Go To: 510) |
| Permissible Values (value): | Bladder (1) |
|
| |
| |
| |
| |
| |
| |
| | Head & neck (mouth, nose, and throat) (8) |
|
| |
| |
| |
| |
| | Lymphoma, including Hodgkins (13) |
|
| |
| |
| |
| |
| | Skin (melanoma, no basal or squamous) (18) |
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
* 1052 | Is hepatocellular carcinoma (HCC) the type of liver cancer the participant has been diagnosed with? (Go To: 510) |
| Permissible Values (value): | No (0) |
|
| |
728 | Cancer type/location (Other, specify) (Go To: 510) |
510 | Date of diagnosis (MM/YYYY) (Go To: 996) |
1206 | Is pathology report for current hepatocellular carcinoma available? (Go To: 1051) |
| Permissible Values (value): | No (0) |
|
| |
968 | Date of procedure that generated pathology report (MM/DD/YYYY): (Go To: 706) |
706 | Method of acquisition (Go To: 1711) |
| Permissible Values (value): | Biopsy (1) |
|
| | Excised during surgery (2) |
|
| |
| |
* 1711 | Were any imaging tests performed since last routine contact? (Go To: 514) |
| Permissible Values (value): | No (0) |
|
| |
| |
* 1051 | Number of liver imaging tests performed since participant's last routine study contact: (Go To: 955) |
955 | Date of imaging test (MM/DD/YYYY): (Go To: 956) |
956 | Type of abdominal imaging: (Go To: 965) |
| Permissible Values (value): | Ultrasound (1) |
|
| |
| |
| |
| | Other, specify: (97) (Go To: 957) |
|
957 | Type of abdominal imaging (other, specify): (Go To: 965) |
965 | Number of lesions (Go To: 966) |
966 | Maximum diameter of largest lesion (in cm) (Go To: 958) |
958 | Evidence of arterial hypervascularization? (Go To: 959) |
| Permissible Values (value): | No (0) |
|
| |
959 | Evidence of portal vein thrombosis? (Go To: 960) |
| Permissible Values (value): | No (0) |
|
| |
960 | Evidence of metastases, including extrahepatic portal or hepatic vein? (Go To: 514) |
| Permissible Values (value): | No (0) |
|
| |
514 | Have you had any full-blooded brothers, sisters, sons, or daughters born into your family since last routine study contact? [Not including half-siblings, step-siblings, or step-children.] (Go To: 1086) |
| Permissible Values (value): | No (0) |
|
| |
| |
870 | Number of blood-related daughters born into participant's family since last routine study contact: (How many blood-related daughters have been born into your family since your last routine study contact?) [Not including adopted, foster, or step-daughters] (Go To: 869) |
869 | Number of blood-related sons born into participant's family since last routine study contact: (How many blood-related sons have been born into your family since your last routine study contact?) [Not including adopted, foster, or step-sons] (Go To: 872) |
872 | Number of blood-related brothers born into participant's family since last routine study contact: (How many blood-related brothers have been born into your family since your last routine study contact?) [Not including adopted, foster, half-sisters or step-brothers] (Go To: 871) |
871 | Number of blood-related sisters born into participant's family since last routine study contact: (How many blood-related sisters have been born into your family since your last routine study contact?) [Not including adopted, foster, half-sisters or step-sisters] (Go To: 1086) |
1086 | Have any of your first degree blood relatives (biological parents, siblings, children) been diagnosed with cancer [other than basal/squamous cell skin cancer] since your last routine study contact? [Not including half-siblings, step-siblings, or step-children.] (Go To: 1712) |
| Permissible Values (value): | No (0) |
|
| |
| |
* 1087 | How many of the participant´s living and deceased first degree blood relatives have been diagnosed with cancer [other than basal/squamous cell skin cancer] since last routine study contact? (How many of your living and deceased first degree blood relatives (biological parents, siblings, children) have been diagnosed with cancer [other than basal/squamous cell skin cancer] since your last routine study contact? [Not including half-siblings, step-siblings, step-parents, or step-children].) (Go To: 1201) |
* 1201 | Relative type (mother, brother, etc) (Go To: 520) |
| Permissible Values (value): | Brother (1) |
|
| |
| |
| |
| |
| |
| |
* 520 | Age when diagnosed (Go To: 741) |
* 741 | Cancer type/Location (Go To: 729) |
| Permissible Values (value): | Bladder (1) |
|
| |
| |
| |
| |
| |
| |
| | Head & neck (mouth, nose, and throat) (8) |
|
| |
| |
| |
| |
| | Lymphoma, including Hodgkins (13) |
|
| |
| |
| |
| |
| | Skin (melanoma, no basal or squamous) (18) |
|
| |
| |
| |
| |
| |
| |
| | Other, specify: (97) (Go To: 729) |
|
| |
| |
729 | Cancer type/Location (Other, specify) (Go To: 1712) |
1712 | Was AFP evaluated since last routine contact? (Go To: 1097) |
| Permissible Values (value): | No (0) |
|
| |
| |
* 969 | Date of AFP (MM/DD/YYYY): (Go To: 1035) |
* 1035 | AFP(ng/ml): (Go To: 1097) |
1097 | Comments (do not include any participant identifiers) (Go To: End of Form) |